While the use of bLF in women with iron deficiency (ID) or iron deficiency anemia (IDA) decreased IL-6 levels and increased prohepcidin levels, in patients without ID/IDA, bLF did not affect IL-6 levels but increased prohepcidin levels [178], indicating a selective effect dependent on body iron status. The gene discussed is IL6; the disease is nutritional disorder.